Instructions for Use
Ergostik Blueflow
Serial no.: xx|8|201|yyy and 2203xxxxx
Version: 6 | Release date: 02 August 2022
Page 5
Transport Packaging .................................................................... 81
Ergostik Blueflow .......................................................................... 81
Infectious / Contaminated Single Use Items ................................. 82
...................................................... 83
Technical Data .............................................................................. 83
Installation and Operating Conditions ........................................... 85
Electrical Safety Concept .............................................................. 86
Ergostik Blueflow with Medical Device Cart and Isolation Transformer
Ergostik Blueflow without Medical Device Cart and without Isolation
Transformer .................................................................................. 87
Electromagnetic Compatibility / EMC Guidelines .......................... 88
Emitted Interference Guideline and Manufacturer Declaration ....... 88
Interference Resistance for all ME Systems Guideline and
Manufacturer Declaration ............................................................. 89
Interference Resistance for None-Life-Supporting ME Systems
Guideline and Manufacturer Declaration ....................................... 90
Recommended Safety Distances for Non-Life-Supporting ME
Systems ....................................................................................... 93
Safety of Product and Material
............................................ 94
............................................. 95
........................................................... 96
General Conditions ....................................................................... 96
Warranty Exemption ..................................................................... 96
Packaging and Shipping ............................................................... 97
Authorised Specialist Retail Partner
.................................... 98
Attachment – Declaration of Conformity
.............................. 99